EDITORIAL SECTION

KNOWLEDGE BANK

  • Techno Trends

    Lilly’s Jaypirca Gains FDA Approval for First-Line CLL/SLL Treatment

    Eli Lilly and Company has received approval from the US Food and Drug Administration FDA for an additional indication for Jaypirca pirtobrutinib in adults with previously untreated chronic lymphocytic leukaemia CLL or small lymphocytic lymphoma SLL without a known p deletion The approval enables Jaypirca to be used as a firstline treatment

TOP ARTICLES

  • 5

    Bioprocessing & Bioproduction In-Depth Focus 2025

    Kate Williamson

    The bioprocessing and bioproduction sector of 2025 experiences fundamental changes through continuous processing and digitalization and sustainability and advanced therapeutic advancements. Advances i...

press releasesRead more...

Argenx to Acquire Unnatural Products, Inc., Adding Peptide Discovery Engine to Broaden Immunology Capabilities

Argenx the immunology innovation company today announced a definitive agreement to acquire Unnatural Products Inc UNP adding a macrocyclic peptide discovery engine to its immunology innovation capabilities argenx which already holds a minority stake in UNP will acquire all remaining shares in a tran...

PharmaLogic to Acquire Lantheus' CDMO Business and Springfield, New Jersey Manufacturing Facility

PharmaLogic Holdings Corp the only independent contract development and manufacturing organization CDMO of scale dedicated exclusively to radiopharmaceuticals today announced a definitive agreement to acquire the CDMO business and Springfield New Jersey manufacturing facility from Lantheus Holdings...

Sino Biological Advances AI-Designed Molecule Validation with 4RISETM

AI can generate protein candidates at an unprecedented speed but experimental validation remains essential to determine whether they properly express bind targets and demonstrate the desired biological properties Sino Biological Inc Shenzhen Stock Exchange SZ a global leader in recombinant protein t...

CareValidate Launches First Same-Day Prescription Delivery for Telehealth Brands, Starting with GLP-1 Treatments in Houston

CareValidate the compliance and clinical infrastructure behind some of the fastestgrowing telehealth brands in the country is launching sameday prescription delivery in Houston Telehealth businesses on the CareValidate platform can now offer eligible patients home delivery within hours instead of wa...

09 - 11

Nov 2026

11th Microbiome Movement USA Summit

The Colonnade Hotel, Boston, M...

10 - 11

Nov 2026

Extractables & Leachables Europe

Parkhotel Schӧnbrunn, Vienna,...

10 - 12

Nov 2026

Lab Asset & Facility Management Summit

The Westin Boston Seaport Dist...

11 - 13

Nov 2026

Frontiers in Cancer Science 2026

One Farrer Hotel,1 Farrer Park...

11 - 12

Nov 2026

24 - 25

Nov 2026

24 - 27

Nov 2026

Pharmtech & Ingredients 2026

Crocus Expo, Pavilion 2, Mosco...

LATEST NEWSRead more...

PharmAla Biotech Signs Supply and Data Agreement with Aalborg University Hospital for Danish Randomized Trial of MDMA-Assisted Treatment for Service-Related PTSD

PharmAla Biotech Holdings Inc a biotechnology company focused on the research development and manufacturing of MDXXclass molecules including its proprietary LaNeo MDMA announces that it has signed a Project Supply Agreement the Agreement with the North Denmark Region

PharmAla Signs Agreement and Initiates R&D with Corealis Pharma for GMP Manufacturing of its patented ALA-002 Drug Product

PharmAla Biotech Holdings Inc a biotechnology company focused on the research development and manufacturing of MDXXclass molecules including its proprietary LaNeo MDMA announces that it has signed an agreement with Corealis Pharma Inc Corealis a GMPcompliant contract development

Thermo Fisher Scientific Introduces Value-Priced Thermo Scientific™ AmpSure™ Universal qPCR Master Mixes Without Compromising Performance

Thermo Fisher Scientific the world leader in serving science today introduces the Thermo Scientific AmpSure Universal SYBR Green and Probe Master Mixes Designed for everyday applications the mixes support reliable reproducible quantitative PCR qPCR performance and offer researchers a valuepriced opt...

Polaris Rx Selected by Bristol Myers Squibb to Dispense ZENBEXUS™ (iberdomide), the First FDA-Approved CELMoD Therapy for Multiple Myeloma

Polaris Rx announced today that it has been selected by Bristol Myers Squibb to dispense ZENBEXUS iberdomide the first cereblon E ligase modulator CELMoD therapy approved by the US Food and Drug Administration FDA ZENBEXUS is approved in combination with daratumumab

Moleculent Introduces Glimt, the First Automated Instrument for Functional Profiling of Cell-Cell Interactions in Human Tissue

Moleculent AB the life sciences technology company pioneering functional profiling today announced Glimt an automated platform that detects cellcell interactions directly in formalinfixed paraffinembedded FFPE tissue The Glimt platform is now available to selected academic

Rhythm Pharmaceuticals and LG Chem Enter into Amendment to Bivamelagon Exclusive License Agreement

Rhythm Pharmaceuticals Inc announced an amendment to the global exclusive license agreement with LG Chem Ltd for bivamelagon an investigational oral smallmolecule melanocortin receptor MCR agonist The Company also announced a fiveyear term loan facility led by KKR